IDIOTYPE VACCINATION AFTER BMT FOR B CELL MALIGNANCIES
IDIOTYPE VACCINATION AFTER BMT FOR B CELL MALIGNANCIES
批准号:
6219356
负责人:
RONALD LEVY
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
关键词:
B lymphocyte active immunization autologous transplantation bone marrow transplantation clinical research dendritic cells human subject human therapy evaluation immunotherapy leukocyte activation /transformation multiple myeloma neoplasm /cancer therapy neoplasm /cancer vaccine nonHodgkin's lymphoma
中文摘要
本试验评估了制定一种新型疫苗的可行性,以刺激抗肿瘤免疫反应,并为完成高剂量干细胞拯救治疗的B细胞恶性肿瘤患者提供治疗益处。每个月的疫苗包括两次治疗,用自体外周血树突状细胞(专业抗原提呈细胞)采集,以个体化肿瘤独特型为靶标进行脉冲并重新输注,然后在ISAF佐剂中注射五次独特型与KLH偶联的皮下注射。4例非霍奇金淋巴瘤患者和26例多发性骨髓瘤患者已完成疫苗接种课程。另有7名患者正在接种疫苗,还有几名患者计划很快开始接种。树突细胞收集足够,再输注耐受良好,几乎没有毒性。3例淋巴瘤患者接种疫苗后出现体液和/或细胞增殖反应。26例骨髓瘤患者中有3例在接种疫苗后出现细胞增殖反应;这些反应与高剂量治疗和干细胞移植后获得完全肿瘤反应显著相关。评估在同种异体移植环境中使用这些免疫方法的可能性。
英文摘要
This trial evaluates the feasibility of formulating a novel vaccine to stimulate anti-tumor immune responses and provide therapeutic benefit for patients with B cell malignancies who have completed high dose therapy with stem cell rescue. The monthly vaccines consists of two treatments with autologous peripheral blood dendritic cells (professional antigen presenting cells) collected by apheresis, pulsed with individualized tumor idiotype as target and reinfused, followed by five doses of idiotype coupled to KLH in an ISAF adjuvant injected subcutaneously. Four patients with non-Hodgkin's lymphoma and 26 patients with multiple myeloma have completed the vaccination course. An additional seven patients are in the process of being vaccinated and several more are scheduled to start soon. The dendritic cell collections have been adequate and the reinfusions have been very well tolerated with next to no toxicity. Three of the lymphoma patients developed humoral and/or cellular proliferative responses after vaccination. Three of the 26 myeloma patients developed cellular proliferative responses after vaccination; such responses were strikingly correlated with attainment of a complete tumor response following high dose therapy and stem cell transplant. Evaluation of the possiblity of using these immune approaches in the allotransplant setting is in place.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
-
批准号:10620636
-
项目类别:
-
资助金额:$51.5万
-
财政年份:2020
-
负责人:RONALD LEVY
-
依托单位:
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
-
批准号:10394950
-
项目类别:
-
资助金额:$51.24万
-
财政年份:2020
-
负责人:RONALD LEVY
-
依托单位:
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
-
批准号:10237935
-
项目类别:
-
资助金额:$52.25万
-
财政年份:2020
-
负责人:RONALD LEVY
-
依托单位:
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
-
批准号:10229582
-
项目类别:
-
资助金额:$84.93万
-
财政年份:2016
-
负责人:RONALD LEVY
-
依托单位:
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
-
批准号:10474287
-
项目类别:
-
资助金额:$82.04万
-
财政年份:2016
-
负责人:RONALD LEVY
-
依托单位:
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
-
批准号:9755369
-
项目类别:
-
资助金额:$85.3万
-
财政年份:2016
-
负责人:RONALD LEVY
-
依托单位:
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
-
批准号:9185919
-
项目类别:
-
资助金额:$92.41万
-
财政年份:2016
-
负责人:RONALD LEVY
-
依托单位:
Therapeutic In Situ Vaccination for Human Lymphoma
-
批准号:8754488
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2014
-
负责人:RONALD LEVY
-
依托单位:
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
-
批准号:8830925
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2011
-
负责人:RONALD LEVY
-
依托单位:
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
-
批准号:8103659
-
项目类别:
-
资助金额:$49.15万
-
财政年份:2011
-
负责人:RONALD LEVY
-
依托单位:
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
-
批准号:8444348
-
项目类别:
-
资助金额:$45.97万
-
财政年份:2011
-
负责人:RONALD LEVY
-
依托单位:
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
-
批准号:8232070
-
项目类别:
-
资助金额:$49.02万
-
财政年份:2011
-
负责人:RONALD LEVY
-
依托单位:
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
-
批准号:8628787
-
项目类别:
-
资助金额:$47.32万
-
财政年份:2011
-
负责人:RONALD LEVY
-
依托单位:
Lymphoma
-
批准号:8180987
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2010
-
负责人:RONALD LEVY
-
依托单位:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
-
批准号:8111155
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2010
-
负责人:RONALD LEVY
-
依托单位:
MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMA
-
批准号:8181391
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2010
-
负责人:RONALD LEVY
-
依托单位:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
-
批准号:8465200
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2010
-
负责人:RONALD LEVY
-
依托单位:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
-
批准号:8265662
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2010
-
负责人:RONALD LEVY
-
依托单位:
Hematologic Malignancies
-
批准号:10626947
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2007
-
负责人:RONALD LEVY
-
依托单位:
Hematologic Malignancies
-
批准号:10411082
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2007
-
负责人:RONALD LEVY
-
依托单位:
海外基金